Categories
Health

A Child’s Blood Sodium Ranges Had been Dangerously Excessive. What Was the Trigger?

The couple sat in silence as they drove home from Blank Children’s Hospital in Des Moines. Her 5-month-old appeared to be dwarfed by the baby carrier strapped to the back seat. He was tiny. He hadn’t grown since he was 2 months old. He weighed just 10 pounds – barely three pounds more than when he was born.

The baby was breastfed from birth, but his mother immediately noticed that he struggled with it more than his three older brothers. She tried putting her breast milk in a bottle to see if that would be easier for her baby to handle. When that didn’t help, she tried adding baby food. He often spat; sometimes it seemed as if more was coming out than was going in. His pediatrician prescribed him an acid-reducing medication. It didn’t seem to do much either.

Despite his size, he looked healthy. He was active. He was able to achieve all of his milestones. He could hold his head up. He could turn around. His fontanelle, the soft spot on his head, was flat—as it should be. His pediatrician advised patience, but when the boy still hadn’t gained any weight at his 4-month visit, she sent blood samples to the lab.

In the late afternoon, the parents received a call with the results. The baby had worrisome abnormalities in his blood chemistry. The salt level in his blood was very high, so high that he could trigger a seizure. In fact, it was so high that he could die if not addressed. Parents rushed the little boy to Blank Children’s Hospital.

Samples taken in the hospital’s emergency room quickly confirmed the anomaly. The child’s sodium level was 159, more than 10 points above normal. The high number not only told his doctors that he had too much sodium, but also that he didn’t have enough water in his body, that he was very dehydrated.

Normally, when there is too much sodium in the body, the brain triggers the urge to drink in order to absorb more water. The brain also tells the kidneys to retain as much water as possible.

The brain communicates all of this with a hormone called vasopressin. Problems with vasopressin can cause a condition first described in the 1700s as diabetes insipidus (DI) — a disease that produces copious and watery (rotten) urine.

The combination of the child’s high sodium levels and watery, dilute urine immediately led doctors to suspect he had DI. His high sodium levels should have caused his brain to send a vasopressin message to his kidneys to hold on to as much water as possible. And yet his urine consisted almost entirely of water. Why? Wasn’t the pituitary gland in his brain able to make the hormone? Or was there a problem on the news-receiving side in his kidneys?

No matter where the problem started, there were medications that could help. Doctors give the baby two drugs that are normally used to control high blood pressure and that cause the kidneys to excrete sodium. Almost immediately, the baby’s sodium began to drop. This indicated that the baby had DI. If so, was the problem in the brain, where the hormone is made, or in the kidneys? How the problem was handled depended on where it originated.

An MRI was done to look for signs of a problem in the pituitary gland. It looked normal. The problem, his doctors thought, was probably in his kidneys. They sent samples to look for a genetic reason for his abnormality, but those results would not be available for weeks.

In the meantime, they continued to give the baby the medicines that helped him get rid of the salt. And slowly the levels dropped. After a few days on these drugs, the baby’s chemistry was perfectly normal. His parents were told he should start gaining weight now. But he did not do it. By the day the doctors decided the baby was well enough to go home, it still hadn’t gained an ounce.

Parents were instructed to feed the child every three hours 24/7 to help him get the maximum number of calories. They should contact their pediatrician and see a genetics specialist. Then they were sent home. They had a strong feeling that their baby was not ready to leave the hospital. He was brought in with a diagnosis of failure to thrive and he’s still not doing well. He was in the zero percentile on the growth chart. Zero. They brought this argument to the boy’s doctors. He will gain weight now that his chemistry is normal they were told. Just give him time.

The child’s parents felt that he did not have time, that his life was still in danger. So early the next morning, parents and baby were back in the car. They had talked their way through to an appointment with the genetics specialists at the University of Iowa Stead Family Children’s Hospital in Iowa City, two hours away. When they got there, the parents shared their concerns. Was the baby’s inability to gain weight because of his DI? Or was there something else going on?

The child had been tested for cystic fibrosis at Blank Hospital. The test was inconclusive. Dozens of other medical conditions can affect a baby’s growth. Parents and baby were sent to the lab to have blood drawn to check for other genetic abnormalities and to the cardiology department to make sure his heart was normal.

The geneticist also wanted the baby to be evaluated by a pediatric gastroenterologist. It was clear he was having trouble feeding and seemed to spit out much of what he was able to eat. The geneticist turned to Dr. Eyad Hanna, who saw the child later that day. It was only minutes before the gastroenterologist decided the child was too small to send home. Like the child’s parents, he feared that if the baby couldn’t gain weight in the hospital, he might not be able to make it at home either. The baby was taken into Hanna’s care and fed around the clock to try to help him get back on the growth curve. Hanna also turned to a pediatric kidney specialist, Dr. Pat Brophy, who recommended adding plain water to make up for the water the boy lost with his urine. Doctors usually advise mothers not to give their babies water because breast milk contains enough water. But this clearly wasn’t a normal baby. And because of the reflux and difficulty breastfeeding the baby, Brophy also recommended placing a tube in the baby’s stomach — a gastrostomy, or G-tube — to ensure it could get enough calories, medication, and much-needed extra water.

The baby continued to spit up copious amounts of the milk and water he was given. Usually, this type of spitting goes away as an infant’s esophagus lengthens and stomach enlarges. But this baby would not grow at all without more food. Hanna recommended adding baby food and dry food to the milk. He had her enlarge the hole in the bottle’s nipple so the thickened liquid could flow through easily.

And then they waited. Test results trickled in. He didn’t have cystic fibrosis. His heart was perfectly normal. But even as the negative results began to roll in, the baby’s parents could see that he was doing better just because he was getting the calories and most importantly, the water he needed. Every night he got the equivalent of an 8-ounce glass of water through his G-tube. Every day he was fed every three hours to get a total of 1,300 calories. And slowly he started gaining weight – 30-40 grams per day. He stayed in the hospital for almost two weeks, and by the time he and his parents were able to go home he had gained over a pound. He needed a few more months to get back on the growth curve. Only then did they get the results of the genetic test, which confirmed what they already knew: the baby had DI

This baby is now 7 years old. He’s learning to live with his DI. He continues to take the medications that help him get rid of his sodium. He often has to go to the toilet. And he has to drink lots and lots of water to replace whatever he loses in his urine. He’s not as big as his brothers – not yet and maybe never. But he’s still growing and thriving, and that’s more than enough for his parents.

Lisa Sanders, MD, is a contributing writer for the magazine. Her latest book is Diagnosis: Solving the Most Baffling Medical Mysteries. If you have a solved case you want to share, write to her at Lisa.Sandersmdnyt@gmail.com.

Categories
World News

S&P 500 futures are flat close to report ranges forward of Fed summit

A trader works on the New York Stock Exchange (NYSE) in New York on August 20, 2021.

Andrew Kelly | Reuters

S&P 500 futures were lower Thursday after the benchmark surged above 4,500 for the first time in the previous session and ahead of the Federal Reserve’s annual symposium on Friday.

S&P 500 futures lost 0.02% and Nasdaq 100 futures lost 0.1%. The Dow Jones Industrial average futures were unchanged.

The weekly initial jobless claims totaled 353,000 as expected, the Department of Labor reported Thursday morning. Economists polled by Dow Jones expected 350,000 Americans to register as unemployed last week, compared with 348,000 the previous week.

Economic growth in the second quarter was 6.6% according to the second estimate by the Department of Commerce on Thursday. This was a slight upward correction from the previously reported annual increase of 6.5%.

The Federal Reserve’s much-anticipated Jackson Hole Symposium will be held virtually on Friday this year, with many central bank speakers expected to make remarks to the media starting Thursday. At the event, central bankers could share their plan to curb monetary stimulus.

Esther George, president of the Kansas City Fed, told CNBC Thursday morning that “given the progress we’ve seen,” a Fed throttling is “appropriate”, although she did not specify when she thought it should begin.

“If you look at the job growth last month, the month before, if you look at the current level of inflation, I would think that the level of housing we are currently offering is probably not needed in this scenario,” she said “So I would be ready to talk about tapers sooner rather than later.”

Salesforce shares rose 2% in pre-trading hours after the software giant released second-quarter results and forecasts that beat analysts’ estimates. Ulta Beauty increased 5% due to strong results.

Zoom Video’s shares rose more than 2% after Morgan Stanley upgraded the stock and forecast an 18% uptrend.

On Wednesday, the S&P 500 gained 0.22% to close on a record, led by stocks that are benefiting from the economic reopening such as airlines, cruise lines and financial companies. The 500-share average broke above 4,500 for the first time on Wednesday, but closed below that level. The benchmark is up 105% from its pandemic low.

The Nasdaq Composite rose 0.15% and also hit a record close. The Dow Jones Industrial Average rose 39 points.

“While we continue to believe in the secular bull market for US stocks, we have proposed some cash in the face of lower highs (including bearish divergences) on a variety of indicators, weaker August and October seasonality, and the transition of the presidential cycle into its weakest phase in US stocks and declining signals from margin debt, “wrote Stephen Suttmeier, Technical Research Strategist at Bank of America.

The benchmark 10-year government bond yield rose as high as 1.352% on Wednesday as worries about slowing growth in the Delta variant eased, reaching its highest level since the beginning of the month when it returned as high as 1.364%.

CNBC Pro’s Stock Picks and Investment Trends:

“The yield on 10-year government bonds has continued to rise in the last few days and has exploded in [Wednesday’s] act and send a strong message that the US Delta variant of Covid may be peaking, which should build confidence, resume economic reopening and stimulate investment flows towards small caps and cyclical stocks, “said Jim Paulsen, Chief Investment Strategist at the Leuthold Group.

Chairman Jerome Powell will make remarks at the Fed summit on Friday. In response to the pandemic, the Federal Reserve has bought at least $ 120 billion a month in bonds to curb longer-term interest rates and stimulate economic growth.

“Expect investors to keep an eye on the Fed symposium for the remainder of this week for comments on the rate hike or the timing of rate hikes,” Paulsen said. “Either unexpected comments from the Fed or a failure or success in scaling up to 4500 could add additional volatility to the equity and bond markets.”

Several companies reported quarterly earnings on Thursday, including Dell Technologies, Gap, HP and Abercrombie & Fitch.

Become a smarter investor with CNBC Pro.
Get stock picks, analyst calls, exclusive interviews and access to CNBC TV.
Sign in to get started Try it for free today

Categories
World News

Chile’s coronavirus circumstances hit document ranges regardless of vaccine rollout

A health worker administers a dose of the Pfizer BioNTech vaccine against Covid-19 to a man at Medalla Milagrosa Church in Valparaiso, Chile, on April 6, 2021.

JAVIER TORRES | AFP | Getty Images

LONDON – Chile’s vaccination campaign against the coronavirus has been one of the fastest and most extensive in the world, but a recent surge in infections has raised concern beyond its borders.

Almost 40% of the total population of the South American country have received at least one dose of a Covid-19 vaccine, according to statistics from Our World in Data, reflecting one of the highest vaccination rates in the world.

Only Israel and the UK have vaccinated a greater proportion of their population with at least one dose.

Nonetheless, Chile has seen a sharp increase in coronavirus infections in recent weeks, despite the world-famous vaccine rollout and strict bans affecting a large part of its 19 million residents.

The regional director of the Pan American Health Organization has since emphasized that for most countries in the region, vaccines are insufficient to prevent rising infection rates.

The number of daily cases in Chile rose to a record high on April 9, rising to over 9,000 for the first time since the pandemic began and well above the high of nearly 7,000 last summer.

Health Minister Enrique Paris told reporters on Thursday that he hoped the increase in daily cases has now peaked.

“Once we hit that peak, we don’t expect a decrease, but rather a stabilization and then a return to a smaller number of positive patients,” he said, according to Reuters.

What went wrong?

Health experts say the country’s recent surge in cases is partly due to more virulent strains of the virus, easing public health measures, increased mobility, and defiance of simple precautions like physical distancing and wearing a mask.

The center-right government of Chile, led by President Sebastian Pinera, ordered the country’s borders to be closed from March to November 2020, albeit with a few exceptions, before it was decided at the end of last year to reopen them to international passengers.

Shops, restaurants and some resorts have also opened to help boost the country’s pandemic-hit economy.

Passengers in protective suits against the spread of the novel coronavirus disease are queuing at the counters of Arturo Merino Benitez International Airport in Santiago on April 1, 2021, after Chile announced that it would close its borders in April as COVID-19 rose sharply is cases.

MARTIN BERNETTI | AFP | Getty Images

While the country’s vaccination rollout was ahead of most, the spread of a more virulent strain of the virus – like the P.1 variant first spotted in travelers from Brazil – has resulted in a significant spike in cases.

Given the widespread use of CoronaVac, the coronavirus vaccine manufactured by Chinese company Sinovac, questions about the vaccine’s effectiveness have also been raised.

After the head of the China Center for Disease Control and Prevention stated earlier this month that China may need to replace its Covid vaccines or change the way they are administered to make them sufficiently effective.

“We will solve the problem that current vaccines do not have very high protection rates,” said George Gao, director general of China’s CDC, at a conference on April 11th. He has since told the state media that his comments have been misunderstood.

Late-stage data from China’s Covid vaccines remain unpublished, and the data available from the CoronaVac vaccine varies. Brazilian studies found the vaccine to be just over 50% effective and significantly less effective than Pfizer-BioNTech, Moderna, and Oxford-AstraZeneca, while Turkish researchers reported 83.5% effectiveness.

An ambulance leaves Carlos Van Buren Hospital in Valparaiso, Chile on April 6, 2021, overwhelmed by the large number of Covid-19 positive cases.

JAVIER TORRES | AFP | Getty Images

A study published earlier this month by the University of Chile reported that CoronaVac was 56.5% effective in the country two weeks after giving the second doses. It was also crucial, however, that a dose was only 3% effective.

“This would explain why Chile – with one of the most robust vaccine launches in the world, but 93% of the doses sourced from China – has seen a significant spike in cases and a much slower decline in hospital admissions and deaths compared to the early rollouts in.” Israel, UK and US, “said Ian Bremmer, President of Eurasia Group’s Risk Advisory Group, in a research note.

“Chile and the United Arab Emirates are both considering introducing a third dose (a second booster) of the Chinese vaccine accordingly. A change in communication will make the vaccine more hesitant for Chinese vaccines in general,” said Bremmer.

“Comprehensive Strategies”

“I cannot stress this enough – for most countries, vaccines are not going to stop this wave of the pandemic,” PAHO director Carissa Etienne said during a weekly press conference Wednesday. “There just isn’t enough of it to protect everyone in the most at-risk countries.”

Etienne urged policymakers in the region to implement “comprehensive strategies” to accelerate vaccine adoption and stop transmission through best public health measures.

On April 14, America reported more than 1.3 million Covid infections and nearly 36,000 deaths in the past week, according to the United Nations Health Department.

To date, America has recorded 58.8 million cases and more than 1.4 million deaths, making it the worst-hit region in the world.

“We are not acting like a region in the middle of a worsening outbreak,” said Etienne of PAHO, describing South America as the “epicenter” of the virus.

In addition to easing restrictions in some areas, Etienne said that new and highly communicable variants of the virus had accelerated cases sharply. Currently, Brazil, Colombia, Venezuela, Peru and some areas of Bolivia are seeing a sharp increase in infections.

Paraguay, Uruguay, Argentina and Chile are also seeing sustained increases in Covid cases, Etienne said.

Categories
Business

Gasoline demand rebounds to almost regular March ranges, in accordance with newest GasBuddy knowledge

A customer refuels a vehicle at a gas station in Peoria, Illinois.

Daniel Acker | Bloomberg | Getty Images

U.S. gasoline demand is nearing normal levels as Americans took to the streets again amid the economic recovery and the introduction of the Covid-19 vaccine.

Demand is almost at the normal March level and continues to rise according to the latest data from GasBuddy. Thursday demand was 17.5% higher than the average for the four previous Thursdays.

“There has been an impressive rebound in demand over the past few weeks and I continue to be surprised every day,” noted Patrick De Haan, Head of Petroleum Analysis at GasBuddy.

Except for one Sunday, every day since February 20th has seen positive percentage growth. There are, of course, many factors that drive gas demand. One of them could be people driving long distances for Covid-19 vaccines. The spring break could also be a driving force.

Nevertheless, the trend shows an upward trend.

“It’s still March, which means the economy is recovering and we’re approaching summer. All the signs point to higher demand than I think almost everyone expected just a few months ago,” added De Haan.

Source: GasBuddy

The graph above shows the recovery in demand. It compares daily gas mileage to February 2020, which was just before the US stalled.

The data showed that demand last Thursday was 1.8% higher than last Thursday before the Covid lockdown took effect in 2020. However, the data is not seasonally adjusted and February tends to be the weakest month for gas demand .

More consumers on the street combined with a decline in gasoline supplies have pushed prices up.

“On average, Americans pay 14% more to refuel than in February,” said Jeanette McGee, AAA spokeswoman, in a statement on Monday. “Given the increased demand and the tighter gasoline supply, we expect more expensive pump prices with little relief in the coming weeks.”

On Friday, the national average for a gallon of gasoline, according to the AAA, was $ 2.886, up 69 cents or 31.4% year over year.